Effectiveness and safety of fexinidazole for gambiense human African trypanosomiasis and exploration of adherence in outpatients: a phase 3b, prospective, open-label, non-randomised, cohort study
Titel:
Effectiveness and safety of fexinidazole for gambiense human African trypanosomiasis and exploration of adherence in outpatients: a phase 3b, prospective, open-label, non-randomised, cohort study
Auteur:
Kumeso, Victor Kande Betu Perdrieu, Christelle Menétrey, Caroline Kyhi, Médard Ilunga Wa Tete, Digas Ngolo Camara, Mamadou Tampwo, John Kavunga, Papy Camara, Mariame Layba Kourouma, Ansoumane Mindele, Willy Kuziena Masa, Felix Akwaso Mahenzi, Hélène Makaya, Joseph Malu, Tim Mayala Mandula, Guylain Nzambi, Dieudonné Mpoyi Muamba Ntoya, Serge Luwawu Reymondier, Anne Kalonji, Wilfried Mutombo Scherrer, Bruno Mordt, Olaf Valverde
Verschenen in:
The Lancet global health
Paginering:
Jaargang 13 () nr. 5 pagina's e900-e909
Jaar:
2025
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license